XML 25 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Treasury Stock
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Income (Loss)
Balance at beginning of the period (in shares) at Jan. 02, 2021   87,128,000        
Balance at beginning of the period at Jan. 02, 2021 $ 288,418 $ 871 $ 321,678 $ 0 $ (33,744) $ (387)
Balance at beginning of the period (in shares) at Jan. 02, 2021       0    
Increase (decrease) in stockholders equity            
Stock-based compensation 15,474   15,474      
Common stock issued under employee benefit plans (in shares)   641,000        
Common stock issued under employee benefit plans 4,095 $ 6 4,089      
Common stock withheld related to net share settlement of stock-based compensation (in shares)   (42,000)        
Common stock withheld related to net share settlement of stock-based compensation (3,506)   (3,506)      
Other comprehensive income (loss) 740         740
Net income 212,602       212,602  
Balance at end of the period (in shares) at Jan. 01, 2022   87,727,000        
Balance at end of the period at Jan. 01, 2022 517,823 $ 877 337,735 $ 0 178,858 353
Balance at end of the period (in shares) at Jan. 01, 2022       0    
Increase (decrease) in stockholders equity            
Stock-based compensation 17,799   17,799      
Common stock issued under employee benefit plans (in shares)   413,000        
Common stock issued under employee benefit plans 3,821 $ 4 3,817      
Common stock withheld related to net share settlement of stock-based compensation (in shares)   (32,000)        
Common stock withheld related to net share settlement of stock-based compensation (1,861)   (1,861)      
Repurchase of common stock (in shares)       (1,677,000)    
Repurchase of common stock (100,025)     $ (100,025)    
Other comprehensive income (loss) (773)         (773)
Net income 89,693       89,693  
Balance at end of the period (in shares) at Dec. 31, 2022   88,108,000        
Balance at end of the period at Dec. 31, 2022 $ 526,477 $ 881 357,490 $ (100,025) 268,551 (420)
Balance at end of the period (in shares) at Dec. 31, 2022 (1,676,551)     (1,677,000)    
Increase (decrease) in stockholders equity            
Stock-based compensation $ 29,800   29,800      
Common stock issued under employee benefit plans (in shares)   546,000        
Common stock issued under employee benefit plans 1,573 $ 5 1,568      
Common stock withheld related to net share settlement of stock-based compensation (in shares)   (61,000)        
Common stock withheld related to net share settlement of stock-based compensation (2,481)   (2,481)      
Repurchase of common stock 0          
Other comprehensive income (loss) (1,644)         (1,644)
Net income 169,885       169,885  
Balance at end of the period (in shares) at Dec. 30, 2023   88,593,000        
Balance at end of the period at Dec. 30, 2023 $ 723,610 $ 886 $ 386,377 $ (100,025) $ 438,436 $ (2,064)
Balance at end of the period (in shares) at Dec. 30, 2023 (1,676,551)     (1,677,000)